TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, ...

Add Yahoo as a preferred source to see more of our stories on Google. Cancer Cell Spread and oncology or Malignant Cancerous ...

Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion ...

A doctor explains what to know about your risk of colon cancer as he's treating more young patients, including a 22-year-old ...

In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further ...

Posters highlight antigen-independent delivery, differentiated efficacy and broad payload versatility of ultra pH-sensitive ...

TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, ...

The fight for two tumor types is poised to intensify, with BioNTech lining up a challenge to AstraZeneca, while SynOx Therapeutics is planning to enter a market served by companie ...

In a strange medical case, a woman suddenly started hearing voices, and they directed her to seek care for a brain tumor.

FILE: Basketball Hall of Famer Oscar Schmidt passes away after battle with brain tumor ...

A woman was given another chance at life and love at a South Florida hospital.The special moment for Linnoray Hernandez<a ...

Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain malignancy, and create “transcriptional addiction” in cancer. They function via ...